Abstract-Mathematical modeling of drug transport can complement current experimental and clinical investigations to understand drug resistance mechanisms, which eventually will help to develop patient-specific chemotherapy treatments. In this paper, we present a general time-and space-dependent mathematical model based on diffusion theory for predicting chemotherapy outcome. This model has two important parameters: the blood volume fraction and radius of blood vessels divided by drug diffusion penetration length. Model analysis finds that a larger ratio of the radius of blood vessel to diffusion penetration length resulted in to a larger fraction of tumor killed, thereby leading to a better treatment outcome. Clinical translation of the model can help quantify and predict the optimal dosage size and frequency of chemotherapy for individual patients.
I. INTRODUCTION
Colorectal cancer (CRC) is one of the most common malignancies in the world; while metastatic CRC patients are routinely administered with chemotherapy, the five-year survival rate remains low [1] . It is helpful to predict and monitor each individual patient's tumor response to chemotherapy drugs, in the hope that if the treatments are ineffective, they can be aborted in time to avoid accumulation of toxicity in the body as well as to mitigate patient expenses. However, current methods for predicting chemotherapy outcome primarily rely on data gathered through in vitro monolayer cell-culture experiments [2] . Such methods underestimate the influences of drug and microenvironmental factors (e.g., oxygen and nutrient gradients) on drug transport. For example, for a chemotherapeutic agent to successfully reach the tumor site, it has to first reach the blood vessels of the tumor through the circulatory system, cross the blood vessel walls, and traverse through the tumor interstitium [3] . Moreover, many studies have highlighted the role of tumor microenvironment and blood supply in drug resistance to chemotherapy [4] [5] [6] . Taken together, in order to predict the effects of a specific chemotherapy treatment, it is required to (1) study the delivery of chemotherapeutic agents percolating into the Resrach supported in part by the National Science Foundation (NSF) Grant DMS-1263742 (Z.W., V.C.), the NSF SBIR 1315372, the National Institutes of Health (NIH) Grant 1U54CA149196, 1U54CA143837, 1U54CA151668, and 1U54CA143907 (V.C. tumor and (2) take into account the effect of the threedimensional tumor microenvironment in vivo on drug supply.
We have been studying how a tumor's biophysical properties affect drug transport using a combined mathematical modeling and experimental/clinical approach [7] [8] [9] [10] [11] . Specifically, we developed and validated a mechanistic steady-state model for predicting the fraction of tumor killed ( kill f ) by chemotherapy in patients with CRC metastatic to liver [10] . More recently, we developed a timedependent model based on first-principles of cell biophysics that successfully predicted in vitro tumor cellular response to a variety of drugs via two drug delivery methods, free drugs and targeted nanodrugs, across different types of cancers [9] . We found that the targeted nanodrug method is more effective in delivering drugs than the free-drug method and overcomes drug resistance due to improved cellular uptake rates of drug. In this paper, we further extend the timedependent diffusion-based model [9] by accounting for spatial dependence, in order to develop a more clinically relevant mathematical model for predicting tumor response to chemotherapy. Parameter perturbation analysis of the model finds that a larger ratio of b r (blood vessel radius) to L (diffusion penetration length) leads to a higher f kill , indicating a better treatment effect.
II. METHODS

A. Mathematical Model
We extend the previously developed time-dependent diffusion-based model [9] by introducing the space factor into the model:
where ( , ) t  x and ( , ) t  x are the drug concentration and the volume fraction of tumor cells, respectively, both dependent on time and space; D is the diffusivity of the drug, u  the per-volume cellular uptake rate of drug, and k  the death rate of tumor cells due to drug uptake.
Because drug diffusion occurs much faster than the process of cell death, Eq. 1 can be reasonably solved at the steady state, i.e., / 0 t     . The nondimensionalized forms of Eqs. 1 and 2 can then be described as:
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B. Parameter Estimation against Patient Data
We consider a cylindrically symmetric domain surrounding a blood vessel (Fig. 1) . The inner cylinder has a radius b / rL in dimensionless unit, representing the blood vessel at the center of the domain. We also hypothesize that the substrate supply for any location in a tissue is supported by the closest blood vessel, and thus estimate that
is the radius of the influenced tissue volume of the vessel, where BVF (i.e., blood volume fraction) is < 1. The influenced tissue volume refers to a specific block of tissue that relies on this blood vessel for supply of oxygen and other essential chemicals.
We obtain parameter values for b r and L from a CRC patient data set containing 27 cases. As demonstrated in [10] , the predicted kill f for each patient is described as a function of parameters, r b , BVF, and L (diffusion penetration length), all of which can be directly measured from histopathology or imaging data. A least-squares fitting was performed to the measured kill f and BVF. This resulted in estimates of two parameters, b r and L, which produced the best fit. Figure 2 shows a comparison of the predictions with the direct measurements of kill f (see [10] for how to measure kill f from patient histopathology imaging data). The radius of the blood vessels b r = 15.83 μm obtained from this fitting was consistent with published data [13] and also with our histopathology measurements. The diffusion penetration length (L) from regression analysis is 155.06 μm. Using Mathematica, statistically significant P values were obtained from nonlinear regression analysis for both b r and L. (Fig.   2, inset) .
III. RESULTS
We performed a parameter perturbation study and simulated the model (Eqs. 3 and 4) in a cylindrically symmetric domain surrounding a blood vessel (Fig. 1) / rL = 0.1; BVF was set to be 0.054, i.e., the mean of the measured BVF values. For each parameter, we created 11 variations, through a range of +/-50% of the parameter's standard value and with a 10.0% variation interval. Note that a 50% variation has been assumed as reasonable in systems modeling analysis [14] [15] [16] . Accordingly, this generated a total of (11 × 11 =) 121 parameter variation pairs, covering a wider range of parameter space. radius of the outer cylinder) was determined by
. Thus, a larger b / rL or a smaller BVF represented a larger tissue volume relying on the modeled blood vessel for drug transport, and hence would require a longer time to achieve the same kill f .
IV. DISCUSSION
In clinical practice, robust biomarkers have long been used to evaluate and predict chemotherapy outcomes in patients, but our modeling-based approach presented here provides a simpler way to achieve this, possibly at a much earlier stage in the course of treatment. Our approach not only helps to predict the tumor's response to drugs before the start of the treatment (accordingly, lowering the cost and toxicity that the patients might be exposed to), but also provides a quantitative understanding of the biophysical barriers that are responsible for the resistance of cancer cells to chemotherapy. In this study, the model specifically demonstrates that biophysical barriers, especially drug diffusion gradients in the microenvironment in vivo, are significant factors in determining the efficacy of drug delivery, and thus should be considered as equally important as the underlying intrinsic genetic/molecular and cellular programs in understanding chemotherapy resistance.
As demonstrated, blood volume fraction (BVF) for each patient can be used in the mathematical model for the prediction of treatment outcome. It is particularly noteworthy that this parameter can be easily measured from histology images or directly assessed from CT scans (i.e., using the easy-to-obtain CT scans data to quantify BVF; see [10] for an example on predicting chemotherapy outcome based on standard contrast CT imaging data). Accordingly, for each individual patient, an optimal treatment strategy specific to this patient, including dosage and dosing schedule, can be developed prior to the actual treatment. Model analysis shown in Fig. 3 suggests a strategy to improve treatment outcome. That is, to increase BVF (which, in turn, leads to an increase in kill f ), we can promote angiogenesis first at the target tumor site before actual chemotherapy treatment. However, we note here that this strategy is contrary to the concept of current anti-angiogenesis therapy [17] . This model can be used alone to predict the fraction of tumor killed or in combination with other methods such as the apparent diffusion coefficient from diffusion weighted-MRI in predicting tumor size at a future time point.
With necessary modifications, the model concept presented here can be applied to the evaluation of other treatment methods in vivo, such as nanoparticles and immunotherapy. In future development, additional layers of complexity including other factors or biophysical barriers, such as hypoxia and acidic extracellular pH, effect of cellcell and cell-matrix interactions, and effect of chemotherapy on the tumor vasculature will be added to the model to improve the model's predictive power.
V. CONCLUSION
We present a mathematical model to predict time-and space-dependent tumor response to chemotherapy. The model has been validated with clinical CRC patient data. We find that the diffusion-related parameters had a significant impact on the amount of drug delivered to the tumor, suggesting clinical applications of the model. 
